يحاول ذهب - حر
Does US cancer drug nod make Cipla attractive?
April 18, 2025
|Mint Mumbai
Cipla, which makes HIV, respiratory and cancer drugs, is targeting North America with generic launches
Cipla Ltd's shares have surged 6% since last week when it announced the final approval from the US Food and Drug Administration for its generic version of Bristol Myers Squibb's Abraxane, a cancer drug. Does the approval to sell the much-awaited product in the US make Cipla a compelling buy, especially when Trump's tariffs loom?
"One product approval by itself doesn't suddenly make a company more attractive," said Prashant Nair, lead analyst for pharma and healthcare at Ambit Capital. "Earlier-than-expected approval for Abraxane is positive, but tariffs will have a bearing on Cipla."
هذه القصة من طبعة April 18, 2025 من Mint Mumbai.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Mint Mumbai
Mint Mumbai
Parag Parikh’s unlisted shares double on growth, tight supply
Parag Parikh Financial Advisory Services (PPFAS), a boutique asset manager with just six mutual fund schemes, is turning heads—not only among investors in its funds but also among shareholders of its unlisted stock.
2 mins
September 27, 2025

Mint Mumbai
Indian pharma dodges Trump's bullet for now
Mainstay generics not hit by 100% tariff; no clarity on branded copycat versions
3 mins
September 27, 2025

Mint Mumbai
JSW wins Bhushan back in SC review
In a win for JSW Steel Ltd, the Supreme Court has approved the company’s ₹19,700 crore plan to take over bankrupt Bhushan Power and Steel Ltd (BPSL), marking the end of one of India’s longest-running insolvency battles.
2 mins
September 27, 2025

Mint Mumbai
Anahat Singh: The rising star of squash
Singh was one of the fastest movers in the top 100 last season, with 12 titles from 18 PSA events
4 mins
September 27, 2025

Mint Mumbai
How AI is changing the office
The next big thing doesn't always turn out that way. There was a spasmodic moment in the early 2020s when the metaverse was going to be the future.
3 mins
September 27, 2025
Mint Mumbai
BSNL now covers 20 mn+ 4G users
With the formal launch of BSNL's 4G services on India-made technology on Friday, the state-owned telecom operator said its mobile network now serves more than 20 million people in India.
1 min
September 27, 2025

Mint Mumbai
Startup investors misjudge India: Peak XV’s Anandan
‘Every decade brings a 10-fold jump in startup scaling, making it hard to envision outcomes’
3 mins
September 27, 2025

Mint Mumbai
Supreme Court upholds JSW's Bhushan Power buy in review
The Supreme Court in its ruling on Friday said the delays in implementing the resolution plan for Bhushan Power were not attributable to JSW Steel or the CoC, citing legal challenges, property attachments, and other orders.
1 mins
September 27, 2025

Mint Mumbai
Read the signs, make policy that includes people
When my friend was in school in Delhi, his family put him in Russian class rather than Hindi because they thought that it would give him an advantage in a world where the erstwhile USSR was a superpower.
4 mins
September 27, 2025

Mint Mumbai
India's share in H-1B hits a decade's low
US President Donald Trump has accused Indians of abusing the H-IB visa system and announced a onetime $100,000 fee on new visas from next year, a nearly 100-fold jump from the current level. The visa numbers, however, tell another story about recent years.
2 mins
September 27, 2025
Listen
Translate
Change font size